D-1847-2019 Class III Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1847-2019 was initiated by American Health Packaging on Aug 27, 2019 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for the tablets. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 60 cartons.

Recall details

Product Type
Drugs
Report Date
Sep 18, 2019
Initiation Date
Aug 27, 2019
Termination Date
Sep 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60 cartons

Product description

Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH

Reason for recall

Labeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for the tablets.

Distribution pattern

Nationwide

Code information

Lots 186509 and 186982, exp 6/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1847-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1847-2019. Report a data issue: hello@regdatalab.com.